Medical oncologist Ardaman Shergill, MD, specializes in providing comprehensive care to patients with all stages of gastrointestinal cancers, with expertise in treating patients with pancreatic and lower gastrointestinal cancers (appendix, colon, rectum). She has focus in providing comprehensive care to patients with early-onset GI cancers. Her research focuses on clinical investigations of targeted therapies, management of minimal residual disease and improving quality of life in patients with GI cancers. Dr. Shergill is developing clinical trials that use novel therapies to advance clinical care. She serves as executive officer for the gastrointestinal cancers committee at the Alliance for Clinical Trials in Oncology, a National Cancer Institute funded oncology research organization. Dr. Shergill has published research in several peer-reviewed journals, including New England Journal of Medicine, Lancet, Journal of Clinical Oncology, Lancet Oncology, Journal of Clinical Oncology - Precision Oncology, JAMA Oncology, Journal of the American College of Surgeons, Oncology, Annals of Surgical Oncology, etc.